400 Jobs To Go At SmithKline Beecham

11 March 1996

SmithKline Beecham has announced that it is reorganizing its manufacturing sites and that this will result in 400 job cuts in Europe where five plants are to be closed.

In France, two plants will close in Dijon and Pessac, a plant in Rome, Italy, will close, as will one in Gronau, Germany, and another in Zaragoza, Spain, the last two having been announced previously.

There will also be downsizing of two plants; in Crawley in the UK, and in Heppignies, Belgium. The former will work closely with R&D to develop production processes for new products and the initial production for commercial launch. It will also focus on its sterile capabilities. To assist this change some of Crawley's established products will be transferred to other sites. The latter will continue to focus on its core competency of primary and sterile penicillin manufacturing. This will result in the transfer of some production to other sites in the network. Heppignies will also receive sterile packaging of injectables.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight